,,ii  #aafth ,,congress  #ast ,session  
,s4 #bjhi  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,july #aa1     
#bjai ,mr4 ,manchin 7for himself and    
,mr4 ,braun7 introduced the following   
bill2 which was read twice and referred 
to the ,committee on ,health1           
,education1 ,labor1 and ,pensions  ,a   
,,bill  ,to prohibit the labeling of    
certain opioid drugs recommending use   
for long-term chronic pain4  #a4 ,short 
title  ,this ,act may be cited as the   
,,fda ,opioid ,labeling ,accuracy ,act4 
#b4 ,labeling prohibition  7a7 ,in      
general ,notwithstanding any other      
provision of law1 the ,secretary of     
,health and ,human ,services 7referred  
to in this ,act as the ,secretary7 may  
not approve labeling for an extended    
release or long-acting opioid analgesic 
drug unless1 as applicable--  7#a7 the  
labeling provides that such drug is not 
intended for the treatment of chronic   
pain1 except in the case of--  7,a7     
treatment of pain related to cancer2    

7,b7 end-of-life care2 or  7,c7 a       
prescriber determination that1 with     
respect to a particular patient1 other  
non-opioid pain management treatments   
are inadequate or inappropriate2 or     
7#b7 the labeling is consistent with the
 regulations promulgated by the         
,secretary pursuant to subsection 7b74  
7b7 ,study and labeling regulations     
7#a7 ,in general ,not later than #a year
 after the date of enactment of this    
,act1 the ,secretary shall-- 7,a7       
conduct a study on the efficacy of      
opioid analgesic drugs for long-term    
chronic pain management2 and  7,b7 based
 on such study1 promulgate regulations  
regarding the labeling for extended     
release or long-acting opioid analgesic 
drugs1 as scientifically appropriate4   
7#b7 ,updates ,the ,secretary may update
 the regulations promulgated under      
paragraph 7#a77;,b71 as appropriate4